🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Stellate Ganglion Block in Complex Regional Pain Syndrome

RecruitingNAAges 18 Years - 75 YearsAllAnkara City Hospital Bilkent
NCT07129811 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim was to investigate the effect of Stellate Ganglion Blockade, which will be applied in addition to conventional physical therapy, on pain and functionality in patients with poststroke complex regional pain syndrome.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Volunteer male and female patients aged 18-75 * Diagnosed with Complex Regional Pain Syndrome according to the IASP 2012 Diagnostic Criteria * Patient's pain level must be VAS \>4 Exclusion Criteria: * Presence of existing neurological diseases other than rheumatic diseases and stroke * General impairment * Conditions that would constitute a contraindication to application, such as an open wound or sensory deficit in the application area * Presence of active infection * Presence of malignancy * Cognitive dysfunction (mini mental test result \<23)
💊

What it tests

  • Stellate Ganglion Block
📍

Where

1 site
Ankara Bilkent City Hospital
Ankara, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy